NIKKEI 225
27,665.70 -218.08 (-0.78%) HANG SENG
20,053.85 -138.55 (-0.69%) CRUDE OIL
72.76 -0.21 (-0.29%) GOLD FUTURES
1,961.20 -5.70 (-0.29%) DOW
32,717.60 +323.35 (+1.00%) Bitcoin GBP
23,182.53 +772.24 (+3.45%)
Eli Lilly and Company (0Q1G.L)
| Previous close | 225.31 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 2.228B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 0.38 |
| EPS (TTM) | 6.52 |
| Earnings date | 27 Apr 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
3 Dividend Stocks That Have Been Paying Investors Since the 1800s
Three businesses that have not only been around for more than a century but have also been paying dividends going back to the 1800s are Eli Lilly (NYSE: LLY), ExxonMobil (NYSE: XOM), and the Toronto-Dominion Bank (NYSE: TD). Healthcare giant Eli Lilly has been paying a dividend since 1885.
- Simply Wall St.
A Eli Lilly and Company (NYSE:LLY) insider increased their holdings by 1.4% last year
From what we can see, insiders were net buyers in Eli Lilly and Company's ( NYSE:LLY ) during the past 12 months. That...
- Reuters
Boehringer's profit up as Jardiance gains offset higher costs
FRANKFURT (Reuters) -German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy and development costs. Family-owned Boehringer said in its annual report that full-year operating income came in at 4.77 billion euros ($5.17 billion), up from 4.71 billion a year earlier. The Jardiance group of products, managed in a partnership with Eli Lilly, made 5.8 billion euros in sales, a currency-adjusted surge of 39.1%.
